B7-H3 Targeting in Prostate Cancer Radioligand Therapy
Prostate cancer researchers are expanding radioligand therapy beyond PSMA (prostate-specific membrane antigen) with three promising new targets—B7-H3, gastrin-releasing peptide receptor (GRPR) and folate receptor alpha (FRα). Published this week in ... Read More